IMPORTANT JANUARY DEADLINE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/21/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/20/23
SCYX SHAREHOLDER ALERT: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYXPRNewsWire • 11/18/23
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/17/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/16/23
SCYX STOCKHOLDERS: Contact Robbins LLP for Information About Your Rights Against Scynexis, Inc.Business Wire • 11/15/23
CLASS ACTION NOTICE: Berger Montague Advises SCYNEXIS, Inc. (NASDAQ: SCYX) Investors to Inquire About a Securities Fraud Class ActionPRNewsWire • 11/14/23
SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/13/23
ROSEN, TRIAL ATTORNEYS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYXPRNewsWire • 11/11/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SCYNEXIS, Inc. (SCYX) InvestorsBusiness Wire • 11/10/23
Scynexis, Inc. (SCYX) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Scynexis, Inc.Business Wire • 11/09/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SCYNEXIS, Inc. (SCYX) InvestorsBusiness Wire • 11/09/23
ROSEN, A LONGSTANDING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYXBusiness Wire • 11/09/23
SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 11/09/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of SCYNEXIS, Inc. (SCYX) InvestorsBusiness Wire • 11/08/23
SCYX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against SCYNEXIS, Inc.Business Wire • 11/07/23
SCYNEXIS Presents New Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Congress on Trends in Medical Mycology (TIMM)GlobeNewsWire • 10/24/23
The Law Offices of Frank R. Cruz Announces Investigation of SCYNEXIS, Inc. (SCYX) on Behalf of InvestorsPRNewsWire • 10/06/23
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Scynexis, Inc. (SCYX)Business Wire • 09/29/23
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of InvestorsBusiness Wire • 09/29/23
SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating SCYNEXIS, Inc. on Behalf of Scynexis Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 09/29/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of InvestorsBusiness Wire • 09/28/23
SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) due to potential for cross contamination with a non-antibacterial ß-lactam drug substanceGlobeNewsWire • 09/28/23
The Law Offices of Frank R. Cruz Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of InvestorsBusiness Wire • 09/27/23
Scynexis: From Fungal To Bungle, The Brexafemme Recall And A Slippery Slope (Rating Downgrade)Seeking Alpha • 09/26/23
